[Long-Term Efficacy of Vaccination Against Hepatitis B in Newborns: 13 Years' Follow-Up].

W Wu,C Sun,M Jiang,Y Xu,G H Zhang,C B Liu,H L Cao,X M Lin,Z Y Xu
DOI: https://doi.org/10.3760/cma.j.issn.1003-9279.2001.03.012
2001-01-01
Abstract:OBJECTIVE:To evaluate long-term efficacy of hepatitis B vaccination in newborns.METHODS:In the past 13 years we followed up the children who had been immunized with hepatitis B vaccine at birth in 1986 every other year. At each follow-up visit, every child was tested for HBsAg, anti-HBs and anti-HBc.RESULTS:HBsAg positive rate of these birth cohort was low (range between 0.46% and 0.98%) during 13 years' follow-up. Long-term efficacy of the vaccination in preventing HBsAg carriage was confirmed.CONCLUSIONS:Thirteen years later no booster was after needed.
What problem does this paper attempt to address?